Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Oct 21, 2021 10:40am
114 Views
Post# 34032380

RE:RE:RE:Another New Job Posted: Scientist Pharmaceutical Development

RE:RE:RE:Another New Job Posted: Scientist Pharmaceutical Development

 


SPCEO1 wrote: While we do not know the numbers, Paul did mention on a call recently that the US salesforce is now smaller. I would ot be surprised if they have 10 or more fewer sales people than they had previously. Now, that is also offset by additions to other marketing oriented staff but perhaps at a lower cost than a salesperson. I imagine they have a lot of turnover in their sales staff right  now since Trogarzo has not panned out as a big seller, so the better salespeople would have likely moved on to greener pastures. And any new person that turns out to be pretty good likely quickly gets picked off by other pharmas who have drugs that are selling better. 
 

Wino115 wrote:

You can see the influence of the new HR person in how they describe the traits they desire.  I really hope they aren't doing all this hiring without having a high degree of certainty around future prospects to support this larger employee base.  Either that or they are cutting elsewhere.

 

archeo753 wrote:

 

 

Position Summary

The incumbent will be responsible for supporting the development and scale-up of pharmaceutical process at third party suppliers. Preparing and reviewing technical reports to support the development activities.

Key Responsibilities

  • Keep appropriate records of any delegated duties
  • Support deviations, investigations and other quality issues are investigated and resolved.

External Customers

  • Suppliers related to manufacturing
  • Consultants 

Required Qualifications

  • Minimum of 4 to 5 years of relevant experience in a biotechnology/pharmaceutical/CRO environment/exposure to manufacturing environment, technical transfer activities.
  • Bachelor's degree in Chemistry or equivalent.
  • Good understanding of basic analytical chemistry.
  • Understanding of peptide chemistry (or organic chemistry or synthesis).
  • Data analysis, statistical, and trending proficiency.
  • Awareness of quality and regulatory requirements in the pharmaceutical industry.
  • Excellent communicator, and well-organized with superior presentation skills.
  • Knowledge of Word, Excel, Power Point and Outlook.

Personal Qualities for all Staff

  • Demonstrable communications skills (both oral and written)
  • Must be a detail-oriented individual with excellent organizational skills
  • Self-motivated with the ability to prioritize and meet multiple deadline
  • Proficiency with the English language
  • Ability to set goals and meet deadlines
  • Ability to prioritize
  • Ability to generate ideas and identify solutions
  • Ability to work both independently and in a team
  • Team spirit and excellent strategic and operational support to team members
  • Versatility and flexibility

Personal Qualities Specific to the Position

  • Results-oriented
  • Ability to negotiate and to influence others
  • Capable to establish priorities
  • Ability to multi-task with ease
  • Ability to learn quickly and demonstrate curiosity
  • Excellent attention to detail and quality in all matters
  • Fluency in written and oral expression
  • Discretion
  • Creativity
  • Rigor in tasks
  • Available for occasional business travel

 




I think face to face marketing is now less relevant than digital marketing, I was a bit concerned when Paul mentioned in one of the CCs that in his mind post pandemic the sales will resume their growth due to personal visits by their sale force. 

Fact is electronic marketing targeting both the doctors( they do have an influence on patients as their advice would effect patients decisions) and patients is faster, cheaper and more effective. So I think they should reduce their sale force resulting in some cost savings and use the proceeds to expand their digital marketing.

 

 

“Marketing has changed a great deal in recent years with most pharma companies starting to recognize the need for alternative strategies.

It’s true, we live at a time in which people turn to their mobile devices for advice and price comparisons.

Surveys show that one in twenty searches on Google are also health related and it’s not just consumers that use these engines but also the doctors who prescribe them.

At the end of the day, patients and doctors are all consumers of information and pharma marketers must use known marketing strategies to build awareness and attract and convert these consumers.

 

Marketing to patients and doctors require distinct strategies but pharma marketing in general involves the same principles that you find in any other industry.

In many ways, implementing these strategies can take time due to lack of understanding and for the fact that many CEOs are still consumed by the ‘old way of thinking’.”

 

https://healthcareweekly.com/pharma-marketing/

<< Previous
Bullboard Posts
Next >>